| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |